Mesenchymal stromal (stem) cell therapy: an emerging immunomodulatory strategy for the adjunctive treatment of sepsis
- PMID: 24484339
- DOI: 10.1164/rccm.201307-1272LE
Mesenchymal stromal (stem) cell therapy: an emerging immunomodulatory strategy for the adjunctive treatment of sepsis
Comment in
-
Reply: Mesenchymal stromal (stem) cell therapy: an emerging immunomodulatory strategy for the adjunctive treatment of sepsis.Am J Respir Crit Care Med. 2014 Feb 1;189(3):364-5. doi: 10.1164/rccm.201307-1386LE. Am J Respir Crit Care Med. 2014. PMID: 24484340 No abstract available.
Comment on
-
Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?Am J Respir Crit Care Med. 2013 Jun 15;187(12):1287-93. doi: 10.1164/rccm.201301-0036CP. Am J Respir Crit Care Med. 2013. PMID: 23590272 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
